PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Journal of Pathology and Translational Medicine10.4132/jptm.2019.10.24202054195-102Clinicopathologic characteristics of HER2-positive pure mucinous carcinoma of the breastYunjeong Jang, Hera Jung, Han-Na Kim, Youjeong Seo, Emad Alsharif, Seok Jin Nam, Seok Won Kim, Jeong Eon Lee, Yeon Hee Park, Eun Yoon Cho, Soo Youn Chohttp://www.jpatholtm.org/upload/pdf/jptm-2019-10-24.pdf, http://www.jpatholtm.org/journal/view.php?doi=10.4132/jptm.2019.10.24, http://www.jpatholtm.org/upload/pdf/jptm-2019-10-24.pdf
Clinical Breast Cancer10.1016/j.clbc.2012.11.0072013132156-158Resistance to Trastuzumab in HER2-Positive Mucinous Invasive Ductal Breast CarcinomaZora Baretta, Rodrigo Santa Cruz Guindalini, Galina Khramtsova, Olufunmilayo I. Olopadehttps://api.elsevier.com/content/article/PII:S1526820912002728?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1526820912002728?httpAccept=text/plain
Annals of Surgical Oncology10.1007/bf02303864199855447-451Pure mucinous carcinoma of the breast: A clinicopathologic correlation studyEli Avisar, Muhammad Akram Khan, Deborah Axelrod, Krishna Ozahttp://link.springer.com/content/pdf/10.1007/BF02303864.pdf, http://link.springer.com/article/10.1007/BF02303864/fulltext.html, http://link.springer.com/content/pdf/10.1007/BF02303864
Her2-Positive Breast Cancer10.1016/b978-0-323-58122-6.00004-0201963-74HER2-Positive Breast CancerSarah Sammons, Kimberly Blackwellhttps://api.elsevier.com/content/article/PII:B9780323581226000040?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:B9780323581226000040?httpAccept=text/plain
Her2-Positive Breast Cancer10.1016/b978-0-323-58122-6.00014-32019231-237Biosimilars for HER2-Positive Breast CancerHope S. Rugohttps://api.elsevier.com/content/article/PII:B9780323581226000143?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:B9780323581226000143?httpAccept=text/plain
Journal of Breast Cancer10.4048/jbc.2011.14.4.3082011144308Mucinous Carcinoma of the Breast in Comparison with Invasive Ductal Carcinoma: Clinicopathologic Characteristics and PrognosisSoo Youn Bae, Min-Young Choi, Dong Hui Cho, Jeong Eon Lee, Seok Jin Nam, Jung-Hyun Yanghttps://synapse.koreamed.org/DOIx.php?id=10.4048/jbc.2011.14.4.308, https://synapse.koreamed.org/pdf/10.4048/jbc.2011.14.4.308, https://ejbc.kr/DOIx.php?id=10.4048/jbc.2011.14.4.308
Cytopathology10.1111/cyt.120162012246377-384Pure and mixed mucinous carcinoma of the breast: fine needle aspiration cytology findings and review of the literatureJ. Cyrta, F. Andreiuolo, S. Azoulay, C. Balleyguier, C. Bourgier, C. Mazouni, M.-C. Mathieu, S. Delaloge, P. Vielhhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fcyt.12016
American Journal of Clinical Pathology10.1093/ajcp/aqz19420191535583-592Frequency, Clinicopathologic Characteristics, and Follow-up of HER2-Positive Nonpleomorphic Invasive Lobular Carcinoma of the BreastHuina Zhang, Ioana Moisini, Rana M Ajabnoor, Bradley M Turner, Marcus D’aguiar, Xueya Cai, Shan Gao, Qi Yang, Xi Wang, Linda Schiffhauer, David G Hickshttp://academic.oup.com/ajcp/article-pdf/153/5/583/33049390/aqz194.pdf, http://academic.oup.com/ajcp/article-pdf/153/5/583/33049390/aqz194.pdf
Her2-Positive Breast Cancer10.1016/b978-0-323-58122-6.00006-4201995-106Neoadjuvant Treatment of HER2-Positive Breast Cancer—A ReviewPeter A. Fasching, Naiba Nabieva, Frederik Stübs, Michael Untchhttps://api.elsevier.com/content/article/PII:B9780323581226000064?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:B9780323581226000064?httpAccept=text/plain
Her2-Positive Breast Cancer10.1016/b978-0-323-58122-6.00005-2201975-93Central Nervous System Metastases in HER2-Positive Breast CancerJosé Pablo Leone, Ayal A. Aizer, Nancy U. Linhttps://api.elsevier.com/content/article/PII:B9780323581226000052?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:B9780323581226000052?httpAccept=text/plain